Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
Sonia Cerquozzi,1 Carolyn Owen2 1Department of Hematology, University of Calgary, 2Department of Hematology, Tom Baker Cancer Centre, Calgary, AB, Canada Abstract: The introduction of targeted therapy against CD20+ with the monoclonal antibody rituximab has dramatically improved the survival of B-...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2015
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ad072ec049fe487aa308dde7eac61360 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|